Latest filing published 20 Mar 2026 for Cumberland Pharmaceuticals INC, €4,368. Read the official filing
Martin S. Brown Jr. appears in our data through filings on Cumberland Pharmaceuticals Inc shares, published by SEC (Form 4). We count 5 filings; the first trade dates from 24 March 2023 and the latest from 18 March 2026.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 20 March 2026 came the latest disclosure, a share grant for €4,368 in Cumberland Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations